查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1873169

全球印迹系统市场

Blotting Systems
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球印迹系统市场预计到2030年将达到16亿美元。

全球印迹系统市场规模在2024年估计为12亿美元，预计到2030年将达到16亿美元，在分析期间（2024-2030年）内复合年增长率（CAGR）为5.4%。本报告分析的细分市场之一—製药和生物技术终端用户市场，预计将以6.0%的复合年增长率成长，并在分析期结束时达到7.762亿美元。学术和研究终端用户市场预计在分析期内将以5.5%的复合年增长率成长。

美国市场规模估计为3.1亿美元，而中国市场预计将以8.5%的复合年增长率成长。

预计到2024年，美国印迹系统市场规模将达到3.1亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到3.792亿美元，在2024年至2030年的分析期内，复合年增长率（CAGR）将达到8.5%。其他值得关注的区域市场包括日本和加拿大，预计在分析期内，这两个市场的复合年增长率将分别达到3.1%和4.3%。在欧洲，德国的复合年增长率预计将达到约3.8%。

全球印迹系统市场—主要趋势与驱动因素概述

为什么印迹系统对分子生物学研究至关重要

印迹系统是分子生物学中的基础工具，在检测和分析DNA、RNA和蛋白质等生物分子方面发挥着至关重要的作用。诸如Western印迹、Southern印迹和Northern印迹等技术使研究人员能够将核酸和蛋白质转移并固定在膜上，从而能够识别、定量和表征复杂混合物中的特定分子。这些系统在基因研究、诊断和药物研发等众多应用中都至关重要，在这些领域，精确的分子分析不可或缺。印迹系统能够以高特异性和高灵敏度检测低丰度分子，这使得它们对于致力于阐明疾病分子机制和开发标靶治疗的研究人员来说具有不可估量的价值。

科技进步将如何影响印迹系统的未来？

随着技术进步不断提升效率、灵敏度和通量，印迹系统领域正迅速发展。诸如自动化印迹系统等创新技术简化了印迹流程，减少了人工操作，最大限度地降低了误差，从而带来了显着的益处，尤其是在高通量实验室中。增强化学冷光和萤光检测方法的开发显着提高了印迹分析的灵敏度，使得检测微量目标分子成为可能。此外，数位成像和分析软体的整合使研究人员能够获得更准确、可重复的数据，从而有助于结果的解读。这些技术进步使印迹系统更加便捷高效，拓展了其在科研和临床领域的应用范围。

影响印迹系统产业的挑战和市场动态有哪些？

印迹系统市场面临许多挑战和动态动态。其中一个关键挑战是市场对兼具高灵敏度和特异性、成本效益高且易于使用的系统的需求。这促使各公司投资开发更强大、更人性化的系统，以满足不同学科研究人员的多元需求。另一个主要挑战是来自质谱和次世代定序等替代技术的竞争，这些技术具有高通量和多重分析能力。儘管有这些挑战，印迹系统凭藉其成熟的通讯协定、多功能性和研究人员的广泛熟悉度，仍然保持着分子生物学基础技术的地位。此外，个人化医疗和精准分子诊断需求的不断增长也影响市场动态，并持续推动先进印迹技术的应用。

哪些因素正在推动印迹系统市场的成长？

印迹系统市场的成长受多种因素驱动，其中包括蛋白质体学和基因组学研究需求的不断增长，这些研究高度依赖印迹技术进行蛋白质和核酸分析。生物医学研究范围的不断扩大，尤其是在感染疾病和遗传疾病等领域，也推动了对能够提供详细分子层面资讯的先进印迹系统的需求。此外，个人化医疗的兴起需要对病患检体进行精确的分子表征，这也促进了更先进印迹技术的应用。高灵敏度检测方法和自动化系统的开发等技术进步，使印迹分析更加高效，并被更多实验室所采用，进一步推动了市场成长。此外，科学研究中对可重复性和准确性的日益重视，也推动了对能够提供可靠结果的高品质印迹系统的需求。随着研究不断拓展分子生物学的边界，对先进且功能多样的印迹系统的需求预计将进一步推动市场创新和扩张。

部分：

按最终用户划分（製药和生物技术公司、学术和研究机构、医院和诊断实验室）

受访公司范例

  • Advansta Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Cell Signaling Technology, Inc.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • LI-COR, Inc.（LI-COR Biosciences）
  • Merck KgaA
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具来变革市场和竞争情报。

Global Industry Analysts 没有依赖查询通用 LLM（大型语言模型）或产业专用的SLM（小型语言模型），而是建立了一个由世界各地领域专家精心整理的内容库，其中包括视频转录、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

我们最新发布的报告纳入了关税对区域市场的影响，正如全球产业分析师预测的那样，关税将改变企业的竞争地位，而企业的竞争地位将取决于其总部所在地、製造地以及进出口（成品和OEM产品）。这种复杂多变的市场现实将透过微观和宏观市场动态影响竞争对手，包括销货成本增加、盈利下降以及供应链重组。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 亚太其他地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP10754

Global Blotting Systems Market to Reach US$1.6 Billion by 2030

The global market for Blotting Systems estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Pharma & Biotech Companies End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$776.2 Million by the end of the analysis period. Growth in the Academic & Research Institutes End-Use segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$310.0 Million While China is Forecast to Grow at 8.5% CAGR

The Blotting Systems market in the U.S. is estimated at US$310.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$379.2 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Blotting Systems Market - Key Trends and Drivers Summarized

Why Are Blotting Systems Integral to Molecular Biology Research?

Blotting systems are fundamental tools in molecular biology, playing a critical role in the detection and analysis of biomolecules such as DNA, RNA, and proteins. Techniques like Western blotting, Southern blotting, and Northern blotting enable researchers to transfer and immobilize nucleic acids or proteins onto a membrane for further analysis, allowing for the identification, quantification, and characterization of specific molecules within a complex mixture. These systems are indispensable in various applications, including genetic research, diagnostics, and drug development, where precise molecular analysis is crucial. The ability of blotting systems to detect low-abundance molecules with high specificity and sensitivity makes them invaluable for researchers seeking to understand the molecular underpinnings of diseases and develop targeted therapies.

How Are Technological Advancements Shaping the Future of Blotting Systems?

The field of blotting systems is evolving rapidly, driven by technological advancements that are enhancing the efficiency, sensitivity, and throughput of these techniques. Innovations such as automated blotting systems are streamlining the blotting process, reducing manual labor and minimizing errors, which is particularly beneficial in high-throughput laboratories. The development of enhanced chemiluminescence and fluorescence detection methods has significantly improved the sensitivity of blotting assays, enabling the detection of even minute quantities of target molecules. Additionally, the integration of digital imaging and analysis software is providing researchers with more accurate and reproducible data, facilitating better interpretation of results. These technological improvements are making blotting systems more accessible and effective, thereby expanding their applications in both research and clinical settings.

What Challenges and Market Dynamics Are Influencing the Blotting Systems Industry?

The blotting systems market is influenced by a range of challenges and dynamic market forces. One of the key challenges is the need for systems that can deliver high sensitivity and specificity while being cost-effective and easy to use. This has driven companies to invest in the development of more robust and user-friendly systems that can meet the diverse needs of researchers across different fields. Another significant challenge is the competition from alternative technologies, such as mass spectrometry and next-generation sequencing, which offer high-throughput and multiplexing capabilities. Despite these challenges, blotting systems remain a staple in molecular biology due to their established protocols, versatility, and the deep-rooted familiarity of these techniques among researchers. Market dynamics are also shaped by the growing demand for personalized medicine and the need for precise molecular diagnostics, which continue to drive the adoption of advanced blotting technologies.

What Factors Are Driving the Growth of the Blotting Systems Market?

The growth in the blotting systems market is driven by several factors, including the increasing demand for proteomics and genomics research, which relies heavily on blotting techniques for the analysis of proteins and nucleic acids. The expanding scope of biomedical research, particularly in the fields of cancer, infectious diseases, and genetic disorders, is also fueling the need for advanced blotting systems that can provide detailed molecular insights. Additionally, the rise of personalized medicine, which requires precise molecular characterization of patient samples, is driving the adoption of more sophisticated blotting technologies. Technological advancements, such as the development of high-sensitivity detection methods and automated systems, are further propelling market growth by making blotting assays more efficient and accessible to a broader range of laboratories. Moreover, the increasing emphasis on reproducibility and accuracy in scientific research is enhancing the demand for high-quality blotting systems that can deliver reliable results. As research continues to push the boundaries of molecular biology, the need for advanced and versatile blotting systems is expected to grow, driving further innovation and expansion in the market.

SCOPE OF STUDY:

The report analyzes the Blotting Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Laboratories)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Advansta Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Cell Signaling Technology, Inc.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • LI-COR, Inc. (LI-COR Biosciences)
  • Merck KgaA
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Blotting Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Protein Analysis Propels Growth of Blotting Systems
    • Advancements in Imaging Technologies Drive Adoption of Automated Blotting Systems
    • Rising Research in Proteomics Expands the Addressable Market Opportunity
    • Shift Towards High-Throughput Blotting Systems Strengthens the Business Case for Innovation
    • Growing Focus on Precision Medicine Throws the Spotlight on Advanced Blotting Techniques
    • Rising Incidence of Chronic Diseases Spurs Demand for Reliable Diagnostic Tools
    • Here's the Story: How Automation in Laboratories Drives Adoption of Blotting Systems
    • Integration of Blotting Systems with Digital Platforms Generates Competitive Advantages
    • Here's How Environmental and Food Safety Testing Spurs the Need for Efficient Blotting Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Blotting Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Blotting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Blotting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Blotting Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • JAPAN
    • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • CHINA
    • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • EUROPE
    • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Blotting Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Blotting Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Blotting Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • FRANCE
    • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • GERMANY
    • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Blotting Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Blotting Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Blotting Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • INDIA
    • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Blotting Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Blotting Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Blotting Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Blotting Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Blotting Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Blotting Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • AFRICA
    • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2015, 2025 & 2030

IV. COMPETITION